Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

He’s using Biden-era mistakes to tarnish a promising technology.

Political narratives about mRNA have fueled confusion, which leads to mistrust, yet the scientific evidence consistently ...

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?